BB Biotech AG
BB.XMIL
Profitability & Returns
Revenue (TTM)
CHF 809M
▲ +613.1% YoY
Net Income (TTM)
CHF 798M
▲ +661.7% YoY
Op. Margin
–
ROIC
–
Cash Flow & Balance Sheet
FCF (TTM)
CHF 394M
▲ +1.5% YoY
Op. Cash Flow (TTM)
CHF 394M
▲ +1.5% YoY
Net Debt
-CHF 98M
Net Cash Position
Cash & Equiv.
CHF 98M
3Y CAGR: +10.2%
Continue Research
Held by ETFs
BB.XMIL is in 1 US ETF. The largest of them, with BB.XMIL's weight in each:
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BB.XMIL
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.